doi: 10.1007/7854_2024_508. Online ahead of print.
Toxicology and Pharmacological Interactions of Classic Psychedelics
Affiliations
- PMID:39042251
- DOI: 10.1007/7854_2024_508
Item in Clipboard
Toxicology and Pharmacological Interactions of Classic Psychedelics
Kelan Thomas. Curr Top Behav Neurosci..
Display options
Format
Display options
Format
Abstract
As psychedelics are being investigated for more medical indications, it has become important to characterize the adverse effects and pharmacological interactions with these medications. This chapter will summarize what is known about the toxicology and drug-drug interactions for classic psychedelics, such as LSD, psilocybin, DMT, 5-MeO-DMT, mescaline, 2C-B, Bromo-DragonFLY, and 25X-NBOMe.
Keywords: Adverse effects; Drug–drug interactions; Metabolism; Psychedelic; Toxicology.
© 2024. The Author(s), under exclusive license to Springer Nature Switzerland AG.
References
- Abbott KL, Flannery PC, Gill KS, Boothe DM, Dhanasekaran M, Mani S, Pondugula SR (2020) Adverse pharmacokinetic interactions between illicit substances and clinical drugs. Drug Metab Rev 52(1):44–65.https://doi.org/10.1080/03602532.2019.1697283 - DOI
- Ambrose JB, Bennett HD, Lee HS, Josephson SA (2010) Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion. Neurologist 16(3):199–202.https://doi.org/10.1097/NRL.0b013e3181a3cb53 - DOI
- Amsterdam J v, Opperhuizen A, Brink W v d (2011) Harm potential of magic mushroom use: a review. Regul Toxicol Pharmacol 59(3):423–429.https://doi.org/10.1016/j.yrtph.2011.01.006 - DOI
- Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE, Duthaler U, Varghese N, Eckert A, Grünblatt E, Liechti ME (2022a) Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects. Clin Pharma Ther 111(4):886–895.https://doi.org/10.1002/cpt.2487 - DOI
- Becker AM, Klaiber A, Holze F, Istampoulouoglou I, Duthaler U, Varghese N, Eckert A, Liechti ME (2022b) Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy participants. Int J Neuropsychopharmacol:pyac075.https://doi.org/10.1093/ijnp/pyac075
LinkOut - more resources
Full Text Sources
Research Materials